President serves as the guest editor for the Bioengineering’s special issue “Nanoparticles in Therapeutic Applications”

PDX Pharma’s President/CEO, Dr. Wassana Yantasee, is currently serving as the guest editor in the special issue “Nanoparticles in Therapeutic Applications” for the MDPI  Bioengineering  journal. The special issue focuses on nanoparticle development and applications in broad ranges of diseases and delivery routes.

More information can be found here.